| NAME | : | Brigatinib |
| BOBOT | : | 584.1 |
| RUMUS | : | C29H39ClN7O2P |
| THERAPEUTIC INDC | : | The anaplastic lymphoma kinase positive, metastatic non-small cell lung cancer (ALK+ NSCLC), represents only 3-5% of the NSCLC cancer cases, but th... |
| CATEGORIES | : | Kinase Inhibitor |
| STRUCTURE | : |  |